Prevest Denpro Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to consider and approve Unaudited Financial Results ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Prevest Denpro Ltd has informed BSE that its Board of Directors will meet on Wednesday, August 13, 2025, to consider and approve the Unaudited Standalone and Consolidated Financial Results for Q1 FY26 (quarter ended June 30, 2025). The Board will also consider recommending the Final Dividend for FY25, approve the notice and logistics for the 26th Annual General Meeting (to be held via video conferencing), and discuss a proposal to migrate the company's equity shares from the BSE SME Platform to the Main Board. The company is listed on the BSE SME platform under Scrip Code 543363.
The migration proposal from SME to Main Board could improve stock liquidity and institutional participation over time, while the Final Dividend recommendation is a positive sign for shareholders. The Q1 results announcement on August 13 will be the key catalyst for near-term stock movement.